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ABSTRACT
Purpose: We aimed to study effect of melatonin on the blood oxygen transport during hypothermia and rewarming in rats.
Material/methods: Cold exposure was performed on male rats  (body weight 220-270 g, n = 48) for 120 minutes under the box 
water temperature of 19°C; rewarming took the next 120 min, with a mean rate of 0.06°C/min. Melatonin was administered 
intraperitoneally 30 min before the cold exposure (bolus doses of 0.1, 1 or 10 mg/kg, or 1 mg/kg*day for 4 days). Haemoglobin-
oxygen affinity was evaluated by p50 (blood pO2 at its 50% O2 saturation) determined by the ”mixing” method at 37°C, pH 7.4 
and pCO2 40 mm Hg (p50stand) and at actual pH, pCO2 and temperature (p50act). 
Results: After hypothermia and rewarming, the values of p50stand and p50act were 31.5±0.28 and 30.2±0.61 mm Hg, respectively. 
The 0.1 mg/kg of melatonin virtually did not change these values, whereas the larger doses increased them. This effect was 
maximal after the prolonged (4 days) melatonin administration: p50stand rose by 5.4% (p<0.05) and p50act - by 12.9 (p<0.05) 
compared with rats without the melatonin treatment. Melatonin affected the mechanisms of O2 transport by decreasing the 
haemoglobin-oxygen affinity (shifting the oxygen dissociation curve of haemoglobin rightwards) and promoting the tissue 
oxygenation, thereby enhancing the body’s resistance to cold.
Conclusions: The melatonin effect mediated by haemoglobin-oxygen affinity change may be used for the correction of 
metabolic disorders and the improvement of the body’s resistance to low environmental temperature.
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INTRODUCTION
The study of processes and functional regulation in a body 
under the changed (including the lower) body temperature is 
the important medical problem [1]. An increase of the body’s 
resistance to low environmental temperature is especially 
important for the patient reanimation after exposure to cold, 
and the assessment of mechanisms creating the tissue O2 flux 
may help the development of ways for reanimation of a cooled 
body [2].
Haemoglobin-oxygen affinity (HOA) largely determines 
the capillary O2 transfer being confirmed with mathematical 
model calculations for the various conditions [3]. In the 
hamster window chamber model tissue pO2 at 1 h after an 
80% isovolemic blood exchange with polymerised bovine 
haemoglobin (Hb) was 27±3 mm Hg, which was significantly 
higher than baseline (22±2 mm Hg, p<0.50)  [4]. The rise of 
р50 by 1 mm Hg increased the arteriovenous pO2 difference 
by 3.2 mm Hg, thereby enhancing the tissue oxygenation and 
cardiac output under the constant O2 delivery decreased by 
5.8% for the unit of p50 change [5]. Under the hypoxia, O2 
tissue delivery is finely regulated by HOA changes: even a 
small HOA shift can maximally increase the arteriovenous O2 
difference and optimise the O2 tissue delivery, maintaining 
the relatively low hemodynamical load. The physiological 
Hb properties are determined by the protein structure and 
the effects of physicochemical factors (pH, temperature and 
concentrations of cofactors modulating the O2 binding) [6]. 
The functional adaptation of Hb depends on the homotropic 
(cooperativity of O2 binding by various hemes that determines 
the sygmoidal shape of O2 equilibrium curve) and heterotropic 
interactions between the hemes and effector-binding sites. Ре
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The role of absolute temperature among the various factors 
determining the oxygen dissociation curve of Hb (ODC) 
position is unclear [5]. Our previous investigations had 
shown, in rats, the decrease of p50 for actual pH, pCO2 and 
temperature from 33.23±0.70 to 20.63±0.47 mm Hg after the 
body temperature fell, in average, to  23.7±0.240С [7], and 
HOA decrease is favourable during the deep hypothermia due 
to the optimised O2 flux to tissues and its lower fraction spent 
for the free radical reactions that is associated with the less 
marked distresses of prooxidant-antioxidant balance. 
In accordance with its protective function, substantial 
amounts of melatonin are found in tissues and organs that 
have high oxygen consumption such as the brain [8]. Effects 
of melatonin on bovine embryonic development in vitro 
depended on the oxygen tension during the treatment being 
harmful under normoxia and protective under hyperoxia [9]. 
The melatonin effect on the O2-transporting mechanisms, 
including the red blood cell (RBC) deformability, was shown 
under the lipopolysaccharide-induced oxidative stress [10,11]. 
The pineal gland also displayed the morpho-functional 
changes during the dynamic adaptation to hypothermia (+4 0C 
for 3 h; melatonin-forming function enhanced during the first 
15 min and then dramatically fell) [12]. We aimed to study 
the effect of melatonin on the blood oxygen transport during 
hypothermia and rewarming in rats.
MATERIAL AND METHODS
Animals
Animals were anaesthetised by sodium thiopental (50 mg/kg 
intraperitoneally). The male rats  (body weight 220-270 g, n = 
48) were kept for 2 weeks in a constant-climate (temperature 
and humidity) environment with a light/dark cycle of 12/12 h. 
Animals were fed on a laboratory diet with water and food ad 
libitum until use and fasted overnight with free access to water 
before the operation. Operation procedures were performed 
between 8.00 hr and 12.00 hr to avoid the chronobiological 
variations. All the experimental procedures described in this 
paper are in accordance with the Guiding Principles for the 
Care and Use of Animals accepted by the Ethical Committee 
of Grodno Medical University. 
Procedure
We used the combined method of artificial hypothermia and 
the following rewarming. During cooling and rewarming rats 
were placed into the special boxes without direct contact with 
water. Cold exposure lasted 120 min under the box water 
temperature of 19°C; rewarming was performed during the 
next 120 min with a mean rate of 0.06°C/min. Melatonin was 
injected intraperitoneally 30 min before the hypothermia in 
1 ml of 1% ethanol. Depending on the treatment, rats were 
subdivided into 6 groups. Rats of the 1st group received 1.0 ml 
1% ethanol (as a usual solvent for melatonin) intraperitoneally 
and served as a control.  Rats of the 2nd group received 1.0 
ml 1% ethanol and then were exposed to hypothermia and the 
following rewarming. Animals of the 3rd, 4th and 5th groups 
received the bolus injection of melatonin (0.1, 1 and 10 mg/
kg, respectively) immediately before the hypothermia. Rats 
of 6th group were pre-treated with melatonin (1 mg/kg*day, 4 
days), and then were subjected to hypothermia and rewarming. 
Rectal temperature was measured with 10-min intervals using 
the electric thermometer. Mixed venous blood was taken from 
right atrium at the end of rewarming period. 
Blood oxygen transport 
The pO2 and acid-base balance (pH, venous carbon dioxide 
pressure (pCO2), concentration of bicarbonate (HCO3
-), the 
concentration of total carbon dioxide (TСО2), the actual excess 
of buffer bases (ABE), the standard excess of buffer bases 
(SBE) and the standard bicarbonate (SBC)) were measured 
with a micro gas analyser “Synthesis-15” (Instrumentation 
Laboratory) at 37°С with the following correction to the actual 
temperature value. HOA was evaluated by p50 (blood pO2 at 
its 50% O2 saturation) determined by the ”mixing” method at 
37°C, pH 7.4 and pCO2 40 mm Hg (p50stand) [13]. The p50 at 
actual pH, pCO2 and temperature (p50act) was calculated from 
p50stand with Severinghaus’ formula [14] using the temperature 
coefficient of 0.024. ODCs were calculated with Hill’s equation 
using n=2.8. The amounts of Hb and metHb were determined 
spectrophotometrically.
Statistics
The results obtained were analysed statistically using Statistica. 
Data are presented as mean ± standard error of mean (SEM). 
Since the data were not normally distributed, Mann-Whitney 
U-tests for unrelated results were used to compare differences 
between the groups. A p value of <0.05 was accepted as 
statistically significant.
RESULTS
High doses of melatonin (1 and 10 mg/kg and 1 mg/kg*day 
for 4 days) resulted in the weaker fall of body temperature 
(Tab. 1). Rats treated by high doses of melatonin displayed the 
higher rectal temperatures at the end of rewarming than the 
animals treated by 1% ethanol + hypothermia/rewarming. 
Tab. 1 shows the indices of blood oxygen transport. Cold 
exposure and the following rewarming decreased the values 
of pO2 by 2.5±0.55 mm Hg (p<0.05), and SO2 - by 1.5±0.27% 
(p<0.05) vs. control. Bolus melatonin injection in doses of 1 and 
10 mg/kg resulted in a rise of pO2 (by 3.3±0.42, p<0.05, and by 
3.0±0.26 mm Hg, p<0.05, respectively) and SO2 (by 5.2±1.09, 
p<0.05, and by 2.9±0.93%, p<0.05, respectively) compared 
with the hypothermia/rewarming group. Chronic melatonin 
administration (1 mg/kg*day, 4 days) increased pO2 by 3.0±0.26 
mm Hg (p<0.05) vs. the hypothermia/rewarming group. 
Prominent changes in acid-base balance values were absent.Ре
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Melatonin in a dose of 0.1 mg/kg did not substantially 
affect these values, and higher doses increased them (Tab. 1). 
This effect was maximal after the chronic (4-day) melatonin 
administration: p50stand rose by 5.4% (p<0.05), and p50act – by 
12.9% (p<0.05) vs. hypothermia/rewarming group.  ODCs at 
actual pH, pCO2 and temperature were shifted to the right by 
various melatonin doses (Fig. 1).   
DISCUSSION
Melatonin shifted ODC to the right, thereby increasing the 
O2 flux to tissues and reducing the effects of O2 deficiency. 
Melatonin prevents the temperature from falling during 
hypothermia by its thermogenic effect on nocturnal animals. As 
a result, groups that received melatonin (bolus doses of 1 or 10 
mg/kg, or 1 mg/kg*day for 4 days) had a statistically significant 
higher rectal temperature after hypothermia/rewarming. The 
lower pO2 during the hypothermia/rewarming reflected the 
worse tissue O2 delivery and the development of hypoxia. 
HOA decreases with temperature rise because of the 
exothermic nature of oxygenation. This effect may be adaptive, 
if it enhances O2 unloading in parallel to increasing metabolic 
Parameters Control
Hypothermia
/rewarming 
Melatonin
 (0.1 mg/kg)+ 
hypothermia
/rewarming
Melatonin    (1 mg/
kg)+ hypothermia
/rewarming
Melatonin (10 mg/
kg)+
hypothermia
/rewarming
Melatonin 
(1 mg/kg*day, 
4 days) +
hypothermia
/rewarming
n 9 8 7 8 8 8
p50stand, 
mm Hg 30.1±0.55 31.5±0.28* 30.8±0.58 32.3±0.52 * 33.0±0.24 *# 33.2±0.30 *#
p50 act, 
mm Hg 29.0±0.36 30.2±0.61* 31.4±0.74 * 32.3±0.48 *# 33.5±0.35 *# 34.1±0.65 *#
pO2,  
mm Hg 27.9±0.35 25.4±0.50* 26.6±0.37 * 28.6±0.42 # 28.4±0.26 # 28.4±0.26 #
pCO2,  
mm Hg 51.6±1.01 53.8±1.15 52.7±0.78 50.3±0.48 # 52.4±0.61 50.9±0.83
Hb,  g/dl 10.91±0.14 10.70±0.27 10.57±0.16 10.69±0.15 10.70±0.15 10.54±0.14*
SO2, % 27.1±0.64 25.6±0.27 26.3±0.53 30.8±1.09 *# 28.0±0.73 # 28.6±1.10 
pH, units 7.352±0.01 7.344±0.01 7.322±0.01 7.349±0.01 7.341±0.01 7.334±0.01
HCO3
-,  mM 30.3±1.21 29.2±0.67 28.4±0.54 29.4±0.99 29.9±1.02 29.5±0.88
TCO2, mM 32.0±1.32 30.8±0.72 30.1±0.57 31.0±1.00 31.6±1.06 31.2±0.92
ABE, mM 3.21±0.70 3.18±0.57 1.93±0.52 3.54±1.03 3.90±0.79 2.69±0.24
SBE, mM 3.21±0.75 3.18±0.67 1.83±0.59 3.59±1.15 4.18±0.92 2.63±0.31
SBC, mM 26.4±0.75 26.0±0.45 25.1±0.39 26.2±0.79 26.7±0.58 26.4±0.59
Rectal temperature
(hypothermia), 0С 28.4±0.2 28.3±0.1 29.1±0.2# 29.2±0.2# 29.2±0.2#
Rectal temperature
 (rewarming), 0С 35.5±0.2 35.3±0.3 35.9±0.1 36.2±0.1*# 36.3±0.2*# 36.3±0.2*#
Note: Data are expressed as mean ± SEM
            * - significant difference from control group;
           #  - significant difference from hypothermia/rewarming group.
Table 1. Effect of melatonin  on indices of blood oxygen transport and acid-base balance during  hypothermia and  rewarming  in rats.
Figure 1. Oxyhemoglobin dissociation curves at actual pH, 
pCO2 and temperature during the hypothermia and the 
following rewarming combined with various doses of melatonin: 
hypothermia/rewarming (), melatonin (1 mg/kg) + hypothermia/
rewarming ( ), melatonin (10 mg/kg) + hypothermia/rewarming 
(▲), melatonin (1 mg/kg*day, 4 days) + hypothermia/rewarming 
(○).
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rate, or maladaptive, if it inhibits O2 loading during the hypoxia. 
Endothermic processes counteracting the exothermia of this 
reaction include O2-associated release of protons (Bohr effect) 
and anions, just as the oxygenation-induced conformational 
changes. Intraspecies adaptation of Hb function to exogenous 
factors, such as hypoxia and temperature, is usually mediated 
by the changes of intraerythrocytic effector concentration 
[15].
          The ODC position during hypothermia of the entire body 
is largely determined by the influences of temperature, pН and 
pCO2. The ODC position under real values of temperature, pН 
and pCO2 is a compromise between these differently acting 
determinants. The evaluation of acid-base state should take 
in account the intrinsic temperature effect (in our present 
investigations pH and pCO2 changes under standard conditions 
(370C) correspond to acidosis and hypercapnia, but their values 
at real temperatures were different) [7]. The temperature is the 
most significant determinant. Hb oxygenation is an exothermic 
reaction; hence, oxyhemoglobin dissociation consumes 
the heat [16]. This pattern of temperature influence on Hb-
oxygen interaction is typical for the majority of Hbs [17]. 
Willford and Hill [18] considered the dependence between 
p50 and temperature as the mechanism for the prevention 
of misbalance between O2 demands and delivery. The 
temperature influences may be compensated, either due to the 
higher synthesis of thermotolerant Hbs or because of changes 
in HOA modulator synthesis [19]. The last mechanism appears 
to be more realistic for the homeothermic animals. Rats are 
known to have the higher ATP and 2.3-diphosphoglycerate 
concentrations during the hypothermia [20], resulting in a 
weaker temperature influence on the ODC position (weaker 
shift leftwards).  In our experiments, melatonin administration 
was accompanied by the increase of p50act, revealing the 
development of compensatory processes to the effects of low 
temperature.  
Melatonin is synthesised mainly in the pineal gland, and it 
regulates mammalian circadian and seasonal rhythms [21]. It 
has a broad spectrum of physiological functions. For example, 
it is an effective free radical scavenger and thereby defends 
the tissues against an oxidative injury [22]. This suggestion 
about the melatonin mechanism of action is confirmed by the 
cytoprotective effects of this molecule during both acute and 
chronic hypoxic cellular stress [23]. 
Melatonin effect on the mechanisms of blood oxygen 
transport is largely unclear. Chronic administration was 
shown to result in larger amounts of Hb and RBCs [24]. 
In experiments in vitro addition of melatonin to human or 
animal RBCs prevented the hemolysis induced by various 
cytotoxic agents (paraquat, malonic dialdehyde, hydrogen 
peroxide, heavy metal salts etc.), with almost doubling of 
100% hemolysis time, increasing of RBC osmoresistance 
simultaneously with rise of intracellular potassium, slowing 
of membranous protein modification, Hb denaturation and 
hemin release [25,26]. Melatonin was shown effectively 
to reduce perferryl-Hb to methemoglobin [27]. During 
the oxidative stress, melatonin actively enters in RBCs 
and is used for cellular defence by means of the slower Hb 
denaturation and of the inhibited hemin release [28]. It affects 
the erythrocyte deformability [11]. During oxidative stress, it 
can defend RBCs against the stiffening factors [29]. After the 
preincubation with RBCs melatonin was shown to decrease 
the level of thiobarbituric acid reactive substances and enhance 
the erythrocyte membrane fluidity (reduce the membrane 
rigidity) [30]. This substrate reduced the lipid peroxidation 
activity and improved the RBC deformability in rats during 
the lipopolysaccharide-induced sepsis [10,31]. However, the 
intraperitoneal melatonin administration for 5 days weakened 
the oxidative injury induced by diabetes mellitus but did 
not affect the RBC deformability or aggregation [32].  In 
the present study, we observed the increase of p50act with 
melatonin dose including the most prominent change after its 
chronic administration. Worth noting is the similar change in 
p50 at standard conditions – HOA is obviously changed due to 
other modulatory factors than pH, pCO2 and temperature. 
Melatonin has the well-known antioxidant activity in 
specific conditions of reactive oxygen species-dependent 
cellular damage [23]. Melatonin functions via multiple 
receptors, both membrane and nuclear, and it scavenges free 
radicals by processes that do not require the receptor/binding 
site [33]. Antioxidant effects were described, not only for 
melatonin itself, but also for its metabolites (N1-acetyl-N2-
formyl-5-methoxykynuramine, cyclic 3-hydroxymelatonin 
and others) [8]. In addition, HOA may be considered as 
one of the factors participating in the maintenance of body 
prooxidant-antioxidant balance. During the oxidative stress, 
the HOA changes mediated by nitric oxide (NO)-dependent 
mechanisms (in first turn, endothelial) can affect the O2 flux 
to tissues and body prooxidant-antioxidant balance as a whole 
[34]. Effects of melatonin are mediated by its specific receptors 
(МТ 1, МТ 2) [35,36]. Melatonin efficiently interacts with 
various reactive O2 and reactive nitrogen species (receptor-
independent actions). It also regulates upward the antioxidant 
enzymes and regulates downward the pro-oxidant enzymes 
(receptor-dependent actions) [37]. It may change the NO 
synthesis activity [38]. It inhibits and inducible NO syntheses, 
thereby decreasing NO production [39,40]. The positive effects 
of NO and melatonin may have the similar mechanisms. 
These results showed that melatonin administration 
affected the O2 transporting mechanisms, weakening the 
HOA (shifting ODC rightwards) and promoting the tissue 
oxygenation, thereby enhancing the body’s resistance to 
cold. These effects might be due to its direct action (through 
its specific receptors) and might be mediated by changes in 
blood oxygen transport and prooxidant-antioxidant balance. 
Effects of melatonin mediated by HOA changes may be used 
for correction of the metabolic disorders and enhancement of 
the body’s resistance to low environmental temperatures.Ре
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